Together, these observations support a role for MPZL3 for proliferation in MET-amplified cells, and that HER3-dependent MPZL3 levels may underlie a requirement for HER3 for robust proliferation in MET-amplified cancers. The gene discussed is MPZL3; the disease is cancer.